Beranda › Diabetes Tipe 2 › North Carolina
Uji klinis Diabetes Tipe 2 di North Carolina
36 studi untuk Diabetes Tipe 2 mencari peserta di lokasi di North Carolina.
Kota di North Carolina
- Havelock13 studi
- Durham11 studi
- Winston-Salem9 studi
- Wilmington8 studi
- Charlotte7 studi
- Raleigh6 studi
- Greensboro6 studi
- Greenville5 studi
- Statesville4 studi
Teks studi resmi (Bahasa Inggris)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- Duke University, Durham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- Duke University, Durham
- Houston Methodist, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06906627Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- PharmQuest Life Sciences LLC, Greensboro
- Accellacare Wilmington, Wilmington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cary Cardiology, Cary
- The University of North Carolina at Chapel Hill, Chapel Hill
- Physicians East, PA, Greenville
- dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Javara Inc. - Cape Fear Valley Medical Center, Fayetteville
- PharmQuest Life Sciences, Greensboro
- Centricity Research - Morehead City, Morehead City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Hospital, Durham
- Durham Veterans Affairs Medical Center (Durham VAMC), Durham
- dan 2 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 55 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Medication Management, LLC, Greensboro
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Statesville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- PharmQuest Life Sciences, LLC, Greensboro
- West Clinical Research, Morehead City
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Monroe
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Charlotte
- AURORA-2 Clinical Site, Durham
- AURORA-2 Clinical Site, Greenville
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- M3 Wake Research, Inc - M3 WR, Raleigh
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centricity Research Morehead City Multispeciality, Morehead City
- Wake Forest University Health Sciences, Winston-Salem
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Lucas Research, Inc., Morehead City
- Shelby Clinical Research, Shelby
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- PharmQuest, Greensboro
- Piedmont Healthcare Statesville, Statesville
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07415954Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Eastern Nephrology Associates - Greenville West, Greenville
- Eastern Nephrology Associates - New Bern, New Bern
- Brookview Hills Research Associates, LLC, Winston-Salem
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- PharmQuest, Greensboro
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Durham
- Research Site, Morehead City
- Research Site, Raleigh
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- University of North Carolina at Chapel Hill, Chapel Hill
- Physicians East, Greenville
- Lucas Research Inc, Morehead City
- dan 1 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- West Clinical Research, Morehead City
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684144A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Research Site, Kinston
- Research Site, Raleigh
- Research Site, Winston-Salem
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07662135AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Carteret Medical Group, Morehead City
- Piedmont Healthcare/Research, Statesville
- Accellacare, Winston-Salem
Menerima pesertaFase 3
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Raleigh
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07662109Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Centricity Research - Morehead City, Morehead City
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599982Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Lucas Research, Inc., Morehead City
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07527650Integrating New Skills Into Diabetes Education With CGM
- University of North Carolina at Chapel Hill, Chapel Hill
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT07463209A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- UNC Children's Hospital, Chapel Hill
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Cary
- Research Site, Morehead City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07664553Human Immunodeficiency Virus (HIV) Food Insecurities
- Wake Forest Health Sciences, Winston-Salem
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT04943861Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Mountain Area Health Education Center, Asheville
- Accellacare, Wilmington
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07521475CGM for Management of Type 2 Diabetes in Pregnancy
- University of North Carolina - Chapel Hill, Chapel Hill
Menerima peserta
Usia 18 hingga 50 · Wanita · Diperbarui 29 Jun 2026 · NCT06628453Culturally Tailored Program for Food-Insecure Adults: SPICE-D
- Wake Forest University Health Sciences, Winston-Salem
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT07361341DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- Atrium Health, Charlotte
- Wake Forest University, Winston-Salem
Menerima pesertaStudi observasional
Usia 8 hingga 15 · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT06525259The Treatment of Painful Diabetic Neuropathy With Diet
- AdventHealth Hendersonville, Hendersonville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT07509671Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Duke University - Charlotte Study Sites, Charlotte
- Duke University - Duke Study Site, Durham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05129345Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Foot and Ankle Specialists of the Mid-Atlantic, Raleigh
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2025 · NCT06681428Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.